Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.

Annals of surgery - 1 Nov 2012

Nitsche Ulrich, Rosenberg Robert, Balmert Alexander, Schuster Tibor, Slotta-Huspenina Julia, Herrmann Pia, Bader Franz G, Friess Helmut, Schlag Peter M, Stein Ulrike, Janssen Klaus-Peter

Abstract excerpt

OBJECTIVES: Individualized risk assessment in patients with UICC stage II colon cancer based on a panel of molecular genetic alterations. BACKGROUND: Risk assessment in patients with colon cancer and localized disease (UICC stage II) is not sufficiently reliable. Development of metachronous metas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colonic Neoplasms
Share to Data Interpretation, Statistical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsatellite Instability

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Osteopontin

Share to ras Proteins

Share to Survival Rate

Source

Identifiers

PMID: 23095620
DOI: 10.1097/SLA.0b013e318272de87

Genes

MACC1
BRAF
KRAS
SASH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23095620-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.PMID 23095620Read ↗

Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.Semantic proximity Read ↗

DNA methylation predicts recurrence from resected stage III proximal colon cancer.Semantic proximity Read ↗

Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.Semantic proximity Read ↗

Colon cancer metastasis: MACC1 and Met as metastatic pacemakers.Semantic proximity Read ↗

A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.Semantic proximity Read ↗

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohortSemantic proximity Read ↗

High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients.Semantic proximity Read ↗

Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.Semantic proximity Read ↗

Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancerSemantic proximity Read ↗

SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer.Semantic proximity Read ↗

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.Semantic proximity Read ↗

A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.